AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal

AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal

Source: 
Medical Marketing and Media
snippet: 

AstraZeneca announced plans to acquire Fusion Pharmaceuticals for up to $2.4 billion on Tuesday morning, marking its latest deal focused on opportunities in the radiopharma space.